These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
https://www.zacks.com/stock/news/2206174/these-2-medical-stocks-could-beat-earnings-why-they-should-be-on-your-radar?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2206174
Jan 05, 2024 - The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
0
Why Glaxo (GSK) is Poised to Beat Earnings Estimates Again
https://www.zacks.com/stock/news/2206453/why-glaxo-gsk-is-poised-to-beat-earnings-estimates-again?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2206453
Jan 05, 2024 - Glaxo (GSK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
0
GSK (GSK) Rises But Trails Market: What Investors Should Know
https://www.zacks.com/stock/news/2207242/gsk-gsk-rises-but-trails-market-what-investors-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2207242
Jan 08, 2024 - The latest trading day saw GSK (GSK) settling at $39.64, representing a +1.1% change from its previous close.
0
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
https://www.zacks.com/stock/news/2207963/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2207963
Jan 09, 2024 - Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
0
GSK (GSK) Declines More Than Market: Some Information for Investors
https://www.zacks.com/stock/news/2211130/gsk-gsk-declines-more-than-market-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2211130
Jan 16, 2024 - GSK (GSK) closed at $39.88 in the latest trading session, marking a -0.55% move from the prior day.
0
GSK (GSK) Stock Dips While Market Gains: Key Facts
https://www.zacks.com/stock/news/2213817/gsk-gsk-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2213817
Jan 22, 2024 - GSK (GSK) closed at $39.53 in the latest trading session, marking a -0.38% move from the prior day.
0
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2214220/are-you-a-momentum-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2214220
Jan 23, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for
https://www.zacks.com/stock/news/2216537/analysts-estimate-bristol-myers-squibb-bmy-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2216537
Jan 26, 2024 - Bristol Myers (BMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
GSK Lags Q4 Earnings, Tops Sales, Issues Upbeat '24 Guidance
https://www.zacks.com/stock/news/2218970/gsk-lags-q4-earnings-tops-sales-issues-upbeat-24-guidance?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2218970
Jan 31, 2024 - GSK's revenues benefit from strong growth across all segments, especially the Shingles and RSV vaccines. The company also issues fresh 2024 guidance for all its segments.
0
Top Analyst Reports for Microsoft, Exxon Mobil & Toyota Motor
https://www.zacks.com/commentary/2223276/top-analyst-reports-for-microsoft-exxon-mobil-toyota-motor?cid=CS-ZC-FT-research_daily-2223276
Feb 08, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Exxon Mobil Corporation (XOM) and Toyota Motor Corporation (TM).
0